DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces ...

DiaSorin S.p.A. (IT:DIA) has released an update. DiaSorin S.p.A. reported a strong performance for the first nine months of 2024, with revenues reaching €876 million, a 4% increase at constant ...

NEW YORK – Diasorin reported on Tuesday that its third quarter revenues rose 6 percent year over year with rising demand for the firm's immunodiagnostic assays in the US and Europe. At constant ...